Fate of norepinephrine in sympathetic nerons and by cardiovascular drugs.
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D005730:Ganglionic Blockers / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006801:Humans; D008750:Methyldopa / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009474:Neurons / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D012110:Reserpine / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000378:metabolism* / Q000502:physiology; D013566:Sympathomimetics / Q000494:pharmacology
D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D013566:Sympathomimetics; D008750:Methyldopa; D012110:Reserpine; D009638:Norepinephrine; D006145:Guanethidine